Description
CNX-774 inhibits Bruton’s tyrosine kinase (BTK) and displays potential anticancer and immunosuppressive activities.
Product Unit Size | Cost | Quantity | Stock |
---|
CNX-774 inhibits Bruton’s tyrosine kinase (BTK) and displays potential anticancer and immunosuppressive activities.
Cas No. | 1202759-32-7 |
---|---|
Purity | ≥98% |
Formula | C26H22FN7O3 |
Formula Wt. | 499.50 |
Chemical Name | 4-[4-[[5-fluoro-4-[3-(prop-2-enoylamino)anilino]pyrimidin-2-yl]amino]phenoxy]-N-methylpyridine-2-carboxamide |
IUPAC Name | 4-[4-[[5-fluoro-4-[3-(prop-2-enoylamino)anilino]pyrimidin-2-yl]amino]phenoxy]-N-methylpyridine-2-carboxamide |
Synonym | CNX774 |
Solubility | DMSO 100 mg/mL (200.2 mM) Ethanol 2 mg/mL (4.0 mM) Water Insoluble |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Akinleye A, Chen Y, Mukhi N, et al. Ibrutinib and novel BTK inhibitors in clinical development. J Hematol Oncol. 2013 Aug 19;6:59. PMID: 23958373.
Glycylcycline; protein synthesis inhibitor.
Peptide; GABA potentiator, NMDA negative allost...
Flavonoid glycoside found in Pyrola.
Polyphenol found in many plants and foods.
Protease inhibitor.
Thiazolidinedione; PPARγ agonist.
CCK antagonist.
Cationic antimicrobial peptide, alters bacteria...
5-HT7 and D2/3 antagonist.
Cyclic tetrapeptide; HDAC inhibitor.
Microtubule depolymerization inhibitor.
Peptide; FRP1 antagonist.
Wortmannin analog; PI3K inhibitor.
MELK inhibitor.
Cholesterol ester transfer protein inhibitor.
Src and Abl inhibitor.
AMPK activator.
Endogenous APP peptide cleavage product, primar...
Calcitonin-family peptide, involved in vasodila...
Triterpenoid